Skip to main content
Keyword
Specialties
Allergy & Immunology
Autoimmune
CardioVascular
Clinical Pathways
Dentistry
Dermatology
Emergency & Mobile Medicine
Endocrinology & Diabetes
Gastroenterology
Infectious Diseases
Neurology
Obstetrics & Gynecology
Oncology
Ophthalmology
Pediatrics
Podiatry
Population Health
Psychiatry & Behavioral Health
Pulmonology
Rheumatology & Arthritis
Surgery
Urology
Wound Care
Events
Education
About
Sign In
Search
Keyword
Specialties
Allergy & Immunology
Autoimmune
CardioVascular
Clinical Pathways
Dentistry
Dermatology
Emergency & Mobile Medicine
Endocrinology & Diabetes
Gastroenterology
Infectious Diseases
Neurology
Obstetrics & Gynecology
Oncology
Ophthalmology
Pediatrics
Podiatry
Population Health
Psychiatry & Behavioral Health
Pulmonology
Rheumatology & Arthritis
Surgery
Urology
Wound Care
Events
Education
About
Sign In
Search
Philip He
CIO 2020-22 Durvalumab±Bevacizumab As Adjuvant Therapy In HCC At Risk Of Recurrence After Curative Therapy: EMERALD-2
Peter R. Galle , MD, PhD;
Riccardo Lencioni , MD;
Philip He ;
Jennifer J. Knox ;
Shethah Morgan ;
Jiaqi Fan , MD;
Gordon Cohen ;
Sean Cleary ;
Ann-Lii Cheng , MD, PhD;
Norihiro Kokudo ;
Jian Zhou , MD, PhD;
Joong-Won Park ;
07/23/2021
CIO 2020-4 Transarterial Chemoembolization Combined With Durvalumab±Bevacizumab in Patients With Locoregional HCC (EMERALD-1)
Yasuaki Arai , MD;
Zhenggang Ren ;
Joseph Erinjeri ;
Philip He ;
Shethah Morgan ;
Gordon Cohen ;
Riccardo Lencioni , MD;
Bruno Sangro , MD, PhD;
Masatoshi Kudo , MD, PhD;
Stephen Lam Chan , MD;
Shukui Qin , MD, PhD;
07/23/2021
Featured Webinar
Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications
Upcoming Events
February 2 – February 5
February 27 – March 1
March 17 – March 19
March 27 – March 30
March 31 – April 2
April 21 – April 24
April 30 – May 4
April 30 – May 5
May 1 – May 3
May 19 – May 21
See Full Calendar